PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer
Kristie-Ann Dickson(University of Technology Sydney), Deborah J. Marsh(University of Technology Sydney)
Cited by 12
Related Papers
The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor
|Endocrine Related Cancer|2010|127
Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine
|Frontiers in Bioengineering and Biotechnology|2022|57